Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 19.01 crore in Q1FY24, growth of 26.66% Y-o-Y
Total Income for Q1FY24 grew 10.27% Y-o-Y to Rs. 143.31 crore. Company has set a target of achieving Rs. 750 crore revenue by FY26 Financial
